Aqua Pharmaceuticals

Aqua Pharmaceuticals is a specialty dermatology company based in Lionville, Pennsylvania. The company employs 58 people and generates $50 million in annual revenue. Aqua Pharmaceuticals focuses on acquiring, developing, and marketing prescription medical dermatology products within the United States. Their current product portfolio includes ACTICLATE® (doxycycline hyclate USP) Tablets, CORDRAN® (flurandrenolide USP) Lotion, Cream, and Ointment, 0.05%, FLUOROPLEX® (fluorouracil) 1% Topical Cream, XOLEGEL® (ketaconazole) Gel, 2%, VERDESO® (desonide) Foam, 0.05%, and MONODOX® (doxycycline monohydrate) Capsules. Aqua Pharmaceuticals is committed to expanding its product offerings through various avenues, including developing, licensing, and acquiring products for the treatment of skin conditions. They actively seek opportunities through product development, in-licensing, co-promotion, product or company acquisition, and partnerships. For more information, visit Aqua Pharmaceuticals' website at aquapharm.com.